Pharma · Private company
Almirall, S.A.
Track this companyFree. Adds Almirall, S.A. to your Dealase workspace and tells you when its record changes.
Clinical trials174 recruiting or active
Pipeline programs12From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline12
- KX2-391 Ointment 1%Phase 3 · Actinic KeratosesClinicalTrials.gov · fetched Nov 12, 2026
- KX2-391 Ointment 1%Phase 3 · Actinic KeratosisClinicalTrials.gov · fetched Nov 12, 2026
- SarecyclinePhase 3 · Acne VulgarisClinicalTrials.gov · fetched Nov 12, 2026
- Tirbanibulin ointment 1%Phase 3 · Keratosis, ActinicClinicalTrials.gov · fetched Nov 12, 2026
- 100 mg P005672-HClPhase 2 · Acne VulgarisClinicalTrials.gov · fetched Nov 12, 2026
- 50 mg of KX2-391 Ointment 1%Phase 2 · Actinic KeratosisClinicalTrials.gov · fetched Nov 12, 2026
- 50 mg P005672-HClPhase 2 · Acne VulgarisClinicalTrials.gov · fetched Nov 12, 2026
- LAD603Phase 2 · Alopecia AreataClinicalTrials.gov · fetched Nov 12, 2026
- LAD191Phase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- LAD603Phase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- dapsone gelAcne VulgarisClinicalTrials.gov · fetched Nov 12, 2026
- TirbanibulinKeratosis, ActinicClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials17
- Comparing Sarecycline and Doxycycline Effects on the Skin and Gut Bacteria in Acne.PHASE4 · RECRUITING · started Apr 20, 2026ClinicalTrials.gov NCT07544251 · fetched Nov 12, 2026
- A Study of LAD603 in Adults With Alopecia AreataPHASE2 · RECRUITING · started Dec 17, 2025ClinicalTrials.gov NCT07311564 · fetched Nov 12, 2026
- The Impact of Botox on Neuroimmune Interactions in Atopic DermatitisPHASE1 · ACTIVE_NOT_RECRUITING · started Jul 17, 2025ClinicalTrials.gov NCT06928246 · fetched Nov 12, 2026
- Lebrikizumab in Moderate-to-severe Atopic DermatitisPHASE4 · ACTIVE_NOT_RECRUITING · started Jul 2, 2025ClinicalTrials.gov NCT06906497 · fetched Nov 12, 2026
- A Single and Multiple Ascending Dose Study of LAD603 in Healthy SubjectsPHASE1 · COMPLETED · started Dec 5, 2023ClinicalTrials.gov NCT06200597 · fetched Nov 12, 2026
- Single and Multiple Ascending Dose Study in Healthy Participants and Participants With an Autoimmune DiseasePHASE1 · COMPLETED · started Jul 29, 2022ClinicalTrials.gov NCT06488209 · fetched Nov 12, 2026
- A Study to Evaluate the Safety and Tolerability of Tirbanibulin Ointment 1% in Adult Participants With Actinic KeratosisPHASE3 · COMPLETED · started Jun 28, 2022ClinicalTrials.gov NCT05279131 · fetched Nov 12, 2026
- Patient and Clinician Reported Outcomes for Tirbanibulin Effectiveness and Safety in Actinic KeratosisCOMPLETED · started Mar 9, 2022ClinicalTrials.gov NCT05260073 · fetched Nov 12, 2026
- Patient-reported Outcomes for Sarecycline Effectiveness and Safety (PROSES)COMPLETED · started Mar 9, 2021ClinicalTrials.gov NCT04820673 · fetched Nov 12, 2026
- A Multi-Center Study to Evaluate the Efficacy and Safety of KX2-391 Ointment 1% on AK on Face or ScalpPHASE3 · COMPLETED · started Sep 18, 2017ClinicalTrials.gov NCT03285477 · fetched Nov 12, 2026
- A Multi-Center Study to Evaluate the Efficacy and Safety of KX2-391 Ointment 1% on Actinic Keratosis on Face or Scalp (AK004)PHASE3 · COMPLETED · started Sep 15, 2017ClinicalTrials.gov NCT03285490 · fetched Nov 12, 2026
- Safety and Efficacy Trial of ACZONE (Dapsone) Gel, 7.5% in 9 to 11 Year-Old Patients With Acne VulgarisPHASE4 · COMPLETED · started Oct 31, 2016ClinicalTrials.gov NCT02959970 · fetched Nov 12, 2026
- Activity & Safety Study of KX2-391 Ointment in Participants With Actinic Keratosis on the Face or ScalpPHASE2 · COMPLETED · started Apr 11, 2016ClinicalTrials.gov NCT02838628 · fetched Nov 12, 2026
- A Multi-Center Open-Label Evaluation of the Safety of Sarecycline Tablets in the Treatment of Acne VulgarisPHASE3 · COMPLETED · started Mar 20, 2015ClinicalTrials.gov NCT02413346 · fetched Nov 12, 2026
- Study to Evaluate Safety & Efficacy of Sarecycline in Treatment of AcnePHASE3 · COMPLETED · started Dec 18, 2014ClinicalTrials.gov NCT02320149 · fetched Nov 12, 2026
- Randomized, Double-blind, Placebo-controlled Study to Evaluate Safety & Efficacy of Sarecycline in Treatment of AcnePHASE3 · COMPLETED · started Dec 3, 2014ClinicalTrials.gov NCT02322866 · fetched Nov 12, 2026
- Double-Blind, Placebo-Controlled Study to Evaluate 3 Doses of a Novel Tetracycline in the Treatment of Facial Acne VulgarisPHASE2 · COMPLETED · started Jun 30, 2012ClinicalTrials.gov NCT01628549 · fetched Nov 12, 2026